New weight loss drugs on horizon next year

A new wave of weight-loss drugs will soon hit the market. The Economist reports that Novo Nordisk, the maker of Wegovy and Ozempic, is preparing to launch a pill version of the active ingredient in both drugs with an average weight loss after a year of more than 16%. Eli Lilly, manufacturer of Mounjaro and Zepbound, is also preparing to release a pill with a 12.4% average annual weight loss. The pills are apparently less effective than taking a shot, but the article notes that they’re far more convenient even though patients could more easily skip a daily pill. Improved versions of injectable drugs are also on the horizon.